Document Detail


Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.
MedLine Citation:
PMID:  19886801     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Prompt diagnosis of invasive pulmonary aspergillosis (IPA) remains a challenge. Galactomannan (GM) detection in bronchoalveolar lavage (BAL) fluid by the Platelia enzyme immunoassay aims to further improve upon the test's utility by applying it directly to specimens from the target organ. METHODS: A retrospective analysis of the Platelia assay was performed on BAL samples from 99 evaluable high-risk hematology patients, including 58 with proven or probable IPA. RESULTS: BAL GM demonstrated an improved sensitivity profile (91.3% with an optical density [OD] index cutoff of >or=1.0) in comparison with culture and microscopy (50% and 53.3%, respectively). The diagnostic accuracy as given by the area under the receiver operating characteristic curve was 0.93 (95% confidence interval, 0.88-0.99); further decreasing the OD index cutoff to 0.5 compromised specificity more than it improved sensitivity. Estimates of the positive and negative predictive value of the Platelia assay on BAL samples (OD index, >or=1.0) were 76% and 96%, respectively. The mean BAL GM OD index was not different in neutropenic versus nonneutropenic case patients (3.9 and 4.5, respectively; P = .3); however, a trend toward decreased sensitivity in patients receiving mold-active prophylaxis was noted. CONCLUSION: BAL GM is a valuable adjunctive diagnostic tool to other conventional microbiologic and radiologic studies.
Authors:
Johan Maertens; Vincent Maertens; Koen Theunissen; Wouter Meersseman; Philippe Meersseman; Stef Meers; Eric Verbeken; Gregor Verhoef; Johan Van Eldere; Katrien Lagrou
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America     Volume:  49     ISSN:  1537-6591     ISO Abbreviation:  Clin. Infect. Dis.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-11-10     Completed Date:  2010-01-26     Revised Date:  2010-03-16    
Medline Journal Info:
Nlm Unique ID:  9203213     Medline TA:  Clin Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1688-93     Citation Subset:  IM    
Affiliation:
Department of Hematology, Medical Intensive Care Unit, University Hospital Gasthuisberg, Leuven, Belgium
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bronchoalveolar Lavage Fluid / chemistry*
Case-Control Studies
Hematologic Diseases / complications*,  microbiology*
Humans
Invasive Pulmonary Aspergillosis / diagnosis*
Mannans / analysis*,  chemistry
Middle Aged
Retrospective Studies
Sensitivity and Specificity
Chemical
Reg. No./Substance:
0/Mannans; 11078-30-1/galactomannan
Comments/Corrections
Comment In:
Clin Infect Dis. 2010 Apr 1;50(7):1070; author reply 1071-2   [PMID:  20201671 ]
Clin Infect Dis. 2010 Apr 1;50(7):1070-1; author reply 1071-2   [PMID:  20201672 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipie...
Next Document:  Anti-tumor necrosis factor-alpha-loaded microspheres as a prospective novel treatment for Crohn's di...